Yvonne Kapila | Infections | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Yvonne Kapila — University of California, Los Angeles, United States

Yvonne Kapila
Affiliation University of California, Los Angeles
Country United States
Scopus ID 6603814821
Documents 148
Citations 10,047
h-index 49
Subject Area Infections
Event Global Diseases Research Awards
ORCID 0000-0003-1330-0654

Yvonne Kapila is a researcher affiliated with the University of California, Los Angeles whose scholarly profile is associated with the field of infections. The available bibliographic profile records 148 documents, 10,047 citations, and an h-index of 49. These indicators provide a bibliometric overview of the researcher’s documented scholarly output and citation impact in indexed literature. [1]

Abstract

This article presents an academic recognition profile for Yvonne Kapila, affiliated with the University of California, Los Angeles, United States, in relation to the Innovative Research Award under the Global Diseases Research Awards. The profile summarizes available bibliometric indicators, including 148 documented publications or scholarly documents, 10,047 citations, and an h-index of 49, together with an identified subject area of infections. Bibliometric indicators are commonly used to describe patterns of scholarly productivity and citation influence, although they should be interpreted alongside qualitative evidence concerning research quality, relevance, originality, and contribution. [1]

Keywords

Yvonne Kapila; Innovative Research Award; University of California, Los Angeles; infections; infectious diseases; global diseases research; biomedical research; research impact; bibliometrics; Scopus; ORCID; scholarly publications.[1]

Introduction

Research in infectious diseases and related biomedical fields contributes to understanding disease mechanisms, prevention, diagnosis, treatment, and population-level health outcomes. Contemporary research assessment frequently combines bibliographic evidence with qualitative evaluation to provide a more complete understanding of scholarly contribution. Citation counts and h-index values can offer measurable indicators of scholarly visibility, while publication records provide information about the extent of documented research activity. [1]

Research Profile

The bibliographic information supplied for Yvonne Kapila identifies the University of California, Los Angeles as the institutional affiliation and the United States as the country of affiliation. The Scopus author identifier associated with the profile . The profile records 148 documents, 10,047 citations, and an h-index of 49. [2]

Research Contributions

The reported subject classification of infections places the research profile within a broad area encompassing infectious disease research and related biomedical investigation. Work in this domain can involve fundamental mechanisms, clinical research, translational science, diagnostic development, therapeutic strategies, prevention, and other approaches relevant to understanding infectious conditions. [1]

Publications

The supplied Scopus profile reports 148 documents associated with the researcher. These records represent the indexed publication output available through the cited author profile at the time of the supplied bibliometric assessment.Because individual publication titles, journal names, publication years, authorship positions, and DOI identifiers were not provided in the input data, this article does not assign specific publication-level claims to the researcher without additional bibliographic verification.[2]

Research Impact

The supplied bibliometric indicators indicate measurable scholarly visibility within indexed literature. A total of 10,047 citations and an h-index of 49 provide quantitative indicators of citation activity and sustained citation performance across the documented research record. [3]

Award Suitability

The supplied profile is presented in connection with the Innovative Research Award of the Global Diseases Research Awards. The reported research subject area of infections provides a thematic relationship with an award program focused on global disease research. The documented publication and citation indicators may also provide quantitative evidence of sustained scholarly activity. [4]

Conclusion

Yvonne Kapila’s supplied academic profile reflects a substantial indexed research record associated with the University of California, Los Angeles and the subject area of infections. The reported indicators of 148 documents, 10,047 citations, and an h-index of 49 provide a quantitative description of the researcher’s documented scholarly visibility. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Yvonne Kapila, Author ID 6603814821. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6603814821
  2. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Radaic, A., Malone, E., Lin, S., Curcino Araujo, L. D., Tse, I., Ganther, S., Kamarajan, P., Fenno, J. C., & Hernandez-Kapila, Y. L. (2026). Nisin-loaded solid lipid nanoparticles (SLN-Nisin) mitigate Treponema denticola intracellular infection and restore highly dysregulated host gene expression. Pharmaceuticals, 19(10), 1585.
    https://doi.org/10.3390/ph19101585

  4. ORCID. (n.d.). Yvonne Kapila — ORCID record.
    https://orcid.org/0000-0003-1330-0654

  5. Harutyunyan, L., & Hernandez-Kapila, Y. L. (2026). Dental implant survival, success, and failure in older populations: Beyond chronological age to systemic and local risk profiles. Periodontology 2000. https://doi.org/10.1111/prd.70077

Maryam Karbasi | Infectious Disease | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Maryam Karbasi — Isfahan University of Technology (IUT), Iran

Maryam Karbasi
Affiliation Isfahan University of Technology (IUT)
Country Iran
Scopus ID 6602224242
Documents 32
Citations 378
h-index 9
Subject Area Infectious Disease
Event Global Diseases Research Awards

Maryam Karbasi is a researcher affiliated with Isfahan University of Technology in Iran whose scholarly profile is associated with infectious disease research. The available Scopus information records 32 documents, 378 citations, and an h-index of 9. These indicators provide a bibliometric context for describing research activity and scholarly visibility. [1]

Abstract

Maryam Karbasi, affiliated with Isfahan University of Technology, Iran, is presented in this academic recognition profile in relation to infectious disease research. The documented Scopus profile reports 32 scholarly documents, 378 citations, and an h-index of 9. These bibliometric indicators provide a concise representation of publication activity and citation performance within the indexed scholarly record. The profile is considered in the context of the Best Researcher Award associated with the Global Diseases Research Awards. The recognition framework considers documented research activity, subject relevance, scholarly visibility, and contributions that may support scientific understanding of infectious diseases and antimicrobial resistance. [2]

Keywords

Maryam Karbasi; Best Researcher Award; antimicrobial resistance; infectious disease; Isfahan University of Technology; Iran; Scopus; bibliometrics; research impact; microbiology; infectious disease research; Global Diseases Research Awards. [1]

Introduction

Infectious disease research addresses pathogens, transmission, diagnosis, treatment, prevention, and disease control across laboratory and public health settings. Antimicrobial resistance is an important component of this field because resistant microorganisms can reduce treatment effectiveness and complicate infection management. Research addressing these challenges supports evidence-based approaches to disease prevention and therapeutic development. [2]

Research Profile

The supplied Scopus information identifies Maryam Karbasi with Author ID 6602224242. The reported profile contains 32 documents, 378 citations, and an h-index of 9. These values describe the indexed scholarly record associated with the specified author profile and may change as publications are added, corrected, or newly indexed by bibliographic databases. [1]

Research Contributions

Karbasi’s research profile is positioned within infectious disease scholarship, a field encompassing microbiology, pathogen biology, antimicrobial research, diagnostics, and infection management. The reported publication record provides evidence of sustained scholarly activity in the indexed literature. Assessment of specific contributions should additionally consider research methodology, originality, scientific findings, authorship roles, and relevance to infectious disease research. [3]

Publications

The supplied Scopus record reports 32 documents associated with Maryam Karbasi. This document count provides a quantitative indication of indexed scholarly output but does not independently establish the quality, originality, methodology, or significance of individual publications. Publication-level assessment requires examination of the individual articles, journals, research designs, findings, and citation contexts. [1]

Research Impact

The reported citation count of 378 and h-index of 9 provide quantitative indicators of citation activity within the specified Scopus record. Such measures can help describe scholarly visibility, although citation patterns differ across disciplines, publication years, collaboration structures, and database coverage. Consequently, bibliometric indicators are most informative when interpreted together with qualitative evidence concerning research significance and scientific contribution. [4]

Award Suitability

The Best Researcher Award profile corresponds with the researcher’s stated subject area of infectious disease and the broader focus of the Global Diseases Research Awards. Karbasi’s academic affiliation, documented publication activity, citation record, and h-index provide measurable information for recognition consideration. A comprehensive evaluation should also consider originality, scientific quality, research contribution, publication evidence, and the applicable award assessment criteria. [3]

Conclusion

Maryam Karbasi’s supplied academic profile documents research activity at Isfahan University of Technology in Iran within infectious disease research. The reported Scopus record of 32 documents, 378 citations, and an h-index of 9 provides a quantitative foundation for describing her indexed scholarly presence. Further examination of individual publications can provide additional context for evaluating research quality and contribution. [5]

References

  1. Elsevier. (n.d.). Scopus author details: Maryam Karbasi, Author ID 6602224242. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602224242
  2. Karbasi, M., Yazdian, N., & Vahidian, A. (2012). Development of electro-co-deposited Ni–TiC nano-particle reinforced nanocomposite coatings. Surface and Coatings Technology, 207, 587–593.
    https://doi.org/10.1016/j.surfcoat.2012.07.083

  3. Varzandeh, M., Ehsani Nasab, M. E., Karbasi, M., & Karbasi, M. (2026). Reframing antibacterial strategies through physical targeting: Mechanisms and future directions. Progress in Biophysics and Molecular Biology, 200, 176–198.
    https://doi.org/10.1016/j.pbiomolbio.2026.05.003

  4. Torkaman, R., Darvishi, S., Jokar, M., Kharaziha, M., & Karbasi, M. (2017). Electrochemical and in vitro bioactivity of nanocomposite gelatin-forsterite coatings on AISI 316 L stainless steel. Progress in Organic Coatings, 103, 40–47.
    https://doi.org/10.1016/j.porgcoat.2016.11.029

  5. Jokar, M., Darvishi, S., Torkaman, R., Kharaziha, M., & Karbasi, M. (2016). Corrosion and bioactivity evaluation of nanocomposite PCL-forsterite coating applied on 316L stainless steel. Surface and Coatings Technology, 307, 324–331.
    https://doi.org/10.1016/j.surfcoat.2016.08.094

Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases

Published on by Global Diseases Research

Prof. Kaiming Zhang | Infectious Disease | Best Scientist in Chronic Infectious Diseases 

Professor | Shanxi Medical University | China

Prof. Kaiming Zhang is a researcher affiliated with Shanxi Medical University, Taiyuan, China, recognized for his expanding contributions to contemporary biomedical and clinical research. With 111 scientific publications, 896 citing documents, and over 1,300 citations, he has established a sustained scholarly presence reflected in an h-index of 22, demonstrating both productivity and the growing influence of his work. Dr. Zhang’s research portfolio spans multidisciplinary domains within medical science, contributing to the advancement of evidence-based understanding in areas relevant to public health, disease mechanisms, and clinical outcomes. His publications include peer-reviewed journal articles, emerging preprints, and collaborative studies with more than 120 co-authors, underscoring his strong integration within global scientific networks and cross-institutional partnerships. Through this collaborative engagement, Dr. Zhang actively supports the development of innovative methodologies, robust analytical frameworks, and data-driven insights that inform clinical practice and medical policy. His contributions are widely cited, reflecting their relevance across diverse research communities and their application in ongoing scientific progress. Dr. Zhang’s scholarly activities also demonstrate a commitment to scientific transparency and evolving research dissemination, with work represented across Scopus-indexed platforms and linked to ORCID for interoperable academic identity management. Although specific award information is not listed, the breadth and depth of his output underscore his dedication to advancing medical research and strengthening the global exchange of scientific knowledge. Overall, Dr. Kaiming Zhang exemplifies a modern clinician-researcher whose work enhances understanding of critical health challenges and contributes meaningfully to improved patient care, research innovation, and societal well-being.

Profiles: Scopus

Featured Publications

1. He, Y., Xing, J., Li, J., Zhang, K., & Li, X. (2025). S100A8 and S100A9-mediated keratinocyte affecting T lymphocyte immune imbalance through TLR4/NF-κB in psoriasis. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-96874-y.

2. Liang, H., Wang, Y., Li, J., & Zhang, K. (2025). Crotonylation deficiency of S100A7 K49 promotes psoriatic keratinocyte proliferation through enhanced interaction with RAGE. Scientific Reports, 15(1), 14678. https://doi.org/10.1038/s41598-025-96874-y.

3. Liang, N., Cao, Y., Li, J., & Zhang, K. (2025). Normal dermal mesenchymal stem cells improve the functions of psoriatic keratinocytes by inducing autophagy. Acta Histochemica, 127(1), 152229. https://doi.org/10.1016/j.acthis.2025.152229.

4. Kuroda, K., Sapadin, A., Shoji, T., Fleischmajer, R., & Lebwohl, M. (2001). Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. Journal of Investigative Dermatology, 116(5), 713–720. https://doi.org/10.1046/j.1523-1747.2001.01316.x.
Cited by 124

Prof. Kaiming Zhang advances the molecular understanding of inflammatory and immune-mediated diseases, uncovering pathways that drive disease progression. His work provides essential foundations for developing targeted therapies and improving clinical outcomes worldwide.